TSPAN13
-
Official Full Name
tetraspanin 13 -
Synonyms
Tetraspanin 13;Tetraspan NET-6;Transmembrane 4 Superfamily Member 13;Tetraspanin-13;TM4SF13;Transmembrane 4 Superfamily Member Tetraspan NET-6;NET6;Tspan-13;NET-6;Tspan-13
Recombinant Proteins
- Mouse
- Chicken
- Rat
- Human
- Mus musculus
- Bovine
- Mammalian Cells
- HEK293
- E.coli
- His
- Non
- His&Fc&Avi
- Myc&DDK
Involved Pathway
TSPAN13 involved in several pathways and played different roles in them. We selected most pathways TSPAN13 participated on our site, such as , which may be useful for your reference. Also, other proteins which involved in the same pathway with TSPAN13 were listed below. Creative BioMart supplied nearly all the proteins listed, you can search them on our site.
Pathway Name | Pathway Related Protein |
---|
Protein Function
TSPAN13 has several biochemical functions, for example, calcium channel regulator activity. Some of the functions are cooperated with other proteins, some of the functions could acted by TSPAN13 itself. We selected most functions TSPAN13 had, and list some proteins which have the same functions with TSPAN13. You can find most of the proteins on our site.
Function | Related Protein |
---|---|
calcium channel regulator activity | TMEM110,TSPAN13B,CACNA2D1A,SGK2B,GRM2,STIM2,CAV3,CRISP1,NRXN1,STIM1 |
Interacting Protein
TSPAN13 has direct interactions with proteins and molecules. Those interactions were detected by several methods such as yeast two hybrid, co-IP, pull-down and so on. We selected proteins and molecules interacted with TSPAN13 here. Most of them are supplied by our site. Hope this information will be useful for your research of TSPAN13.
Resources
Related Services
Related Products
References
- Tsukamoto, S; Takeuchi, M; et al. Tetraspanin CD9 modulates ADAM17-mediated shedding of LR11 in leukocytes. EXPERIMENTAL AND MOLECULAR MEDICINE 46:-(2014).
- Dakshinamoorthy, G; Kalyanasundaram, R; et al. Evaluating the efficacy of rBmHAT alpha c as a multivalent vaccine against lymphatic filariasis in experimental animals and optimizing the adjuvant formulation. VACCINE 32:19-25(2013).